59th American Society of Hematology (ASH) Annual Meeting and Exposition | Fate Therapeutics, Inc.

59th American Society of Hematology (ASH) Annual Meeting and Exposition

Dec102017

December 10, 2017 at 12:00 AM EST

December 10, 2017

FT819 iPSC-derived CAR19 T-Cell Cancer Immunotherapy

iPSC-derived CAR NK Cell Cancer Immunotherapy

iPSC-derived Cancer Immunotherapy Product Platform

Supporting Materials

Generation CD8ab+ Cytotoxic T lymphocytes for Off-the-Shelf T Cell Therapy 2.2 MB

iPSC Engineering of Pluripotent Cell Lines for Off-the-shelf NK Cell Immunotherapy 909.3 KB

iPSC-derived CAR NK Cell Immunotherapies with Targeted Anti-Tumor Activity 9.9 MB

MENU